FdaApplication

ANDA 219046

Back to search

Identifiers

Properties

PropertyValue
applicant_nameRISING PHARMA HOLDINGS INC
application_typeANDA
approval_date2025-11-04

Products (1)

ProductActive ingredientStrengthDosage form
SULFASALAZINESULFASALAZINE500MGTABLET;ORAL

1 product